For women with premenstrual dysphoric disorder (PMDD), selective serotonin reuptake inhibitors (SSRIs) are the first line of pharmacological treatment. A significant body of evidence, including numerous double-blind, randomized studies, supports the effectiveness of SSRIs in [...]
Many women have concerns about the side effects of oral contraceptives (birth control pills). Potential side effects include bloating, breast tenderness, and weight gain. In addition, some women may experience depression or mood swings, side [...]
Placentophagy.  That’s a fancy term for describing what some women do after giving birth.  Placentophagy refers to the act of eating the placenta after giving birth.  Almost all non-human placental mammals ingest their placentas after [...]
Nearly a third of postmenopausal women experience vaginal changes, including dryness, itching and pain during sex -- symptoms related to the declining levels of estrogen occurring during the transition to menopause. Â According to a study [...]
Lithium is one of the most effective treatments for patients with bipolar disorder. Â Its use, however, is limited by its potential for serious long-term adverse events, including renal, thyroid, and parathyroid dysfunction. A recent study [...]
Since the Women's Health Initiative (WHI) reported that the risks of menopausal hormone replacement therapy (HRT) outweighed its benefits, there has been a significant reduction in the use of HRT. Â However, since that time, studies [...]
 Over the last decade, numerous studies on the reproductive safety of selective serotonin reuptake inhibitors (SSRIs) have been published.  However, these studies, using different methodologies and studying different populations, have often yielded conflicting results. [...]
SAGE-547 (SAGE Therapeutics) is a new drug, an allosteric modulator of GABAA receptors, which is currently under investigation for the treatment of refractory seizure disorders. Â It turns out that SAGE-547 may also be useful for [...]
Several recent articles indicate that the burden of menopausal symptoms is greater than generally perceived.  About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats — as they transition into the [...]
In healthy perimenopausal women with hot flashes, treatment with both estradiol and venlafaxine resulted in significantly greater improvement in quality of life, as compared to placebo. Estradiol had beneficial treatment effects on all domains of the [...]
